Fudan-Zhangjiang

FDZJ concentrates on the business of R & D, manufacturing, and sales of innovative drugs.

Fudan-Zhangjiang, founded in November, 1996 and headquartered in Shanghai, is a biopharmaceutical developer. The founder is Wang Haibo. Listed on the HKEX on December 16, 2013, the company's major shareholders are Shanghai Pharmaceuticals Holding Co., Ltd., China New Enterprise Phase II Investment Co., Ltd. and Yang Zongmeng. Rivals that have direct and indirect competition with Fudan-Zhangjiang include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Specialty Pharma

Founded

Nov 10, 1996

HQ location

Shanghai, China

Legal name

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

Employees

501-1000

See more